Use of a Glycine B partial agonist as an antipsychotic
US5187171A · kind A · utility
15Cited by
0References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 9, 1989 |
| Grant date | Feb 16, 1993 |
| Priority date | — |
| Expiry date | Jan 9, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A class of Glycine B partial agonists is described for use for treatment of psychosis. Preferred Glycine B partial agonists include amino-isoxazolidone compounds such as D-cycloserine and its prodrugs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.